These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27155971)

  • 1. Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis.
    Lee KH; Kim JK; Lee MA; Ko YB; Yang JB; Kang BH; Yoo HJ
    Arch Gynecol Obstet; 2016 Sep; 294(3):561-6. PubMed ID: 27155971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
    Song SY; Lee SY; Kim HY; Park DB; Kim DE; Lee KH; Lee S; Yang JB; Yoo HJ
    Medicine (Baltimore); 2020 May; 99(22):e20421. PubMed ID: 32481439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis.
    Cho S; Nam A; Kim H; Chay D; Park K; Cho DJ; Park Y; Lee B
    Am J Obstet Gynecol; 2008 Apr; 198(4):373.e1-7. PubMed ID: 18177833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suture fixation of levonorgestrel-releasing intrauterine device using the hysteroscopic cold-knife surgery system: an original method in treatment of adenomyosis.
    Zhu L; Yang X; Cao B; Tang S; Tong J
    Fertil Steril; 2021 Oct; 116(4):1191-1193. PubMed ID: 34238576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF; Singh K
    Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
    Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
    J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levonorgestrel-releasing intrauterine system on lymphangiogenesis of adenomyosis.
    Cho S; Choi YS; Yun BH; Chon SJ; Jung YS; Kim H; Park JH; Seo SK; Kim SH; Lee BS
    Am J Clin Pathol; 2015 Mar; 143(3):352-61. PubMed ID: 25696793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effect of levonorgestrel intrauterine system on heavy menstrual bleeding: is it associated with hemodynamic changes in uterine, radial, and spiral arteries?
    Şahin H; Güngören A; Sezgin B; Ün B; Şahin EA; Dolapçioğlu K; Bayik RN
    J Obstet Gynaecol; 2021 Jan; 41(1):89-93. PubMed ID: 32573299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
    Zhang P; Song K; Li L; Yukuwa K; Kong B
    Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of levonorgestrel intra-uterine system in the management of adenomyosis: A systematic review and meta-analysis of prospective studies.
    Abbas AM; Samy A; Atwa K; Ghoneim HM; Lotfy M; Saber Mohammed H; Abdellah AM; El Bahie AM; Aboelroose AA; El Gedawy AM; Mostafa M; Elsenity MA; Samy M; Safwat S; Abdelrahman RM; Salah El Din AS; Badran E; Abdelkader AM; Abdallah A
    Acta Obstet Gynecol Scand; 2020 May; 99(5):571-581. PubMed ID: 31889294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
    Li L; Leng J; Jia S; Lang J
    Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrauterine device use among women with uterine fibroids: a systematic review.
    Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
    Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel levels in serum and uterine flushings in women bearing LNG-Cu-IUD.
    Shi JP; Wu XR
    J Tongji Med Univ; 1993; 13(2):126-8. PubMed ID: 8230357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
    Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.